BCL2L11 and non-small cell lung carcinoma: Upregulation of FGFR1 in NSCLC cell lines by hypoxia induces subsequent activation of MAPK cascades, leading to attenuated induction of the pro-apoptotic factor Bim, which drives acquired resistance to EGFR tyrosine kinase inhibitors41–44.